Axcelead has two strengths in phenotypic drug discovery.
The first is our compound library, which has over 1.5 million compounds. This extensive compound collection allows us to propose the optimal set of compounds that maximize the potential for a hit in any phenotypic assay system.

Second, we have a highly qualified specialists with extensive experience in phenotypic drug discovery and state-of-the-art facilities that allow for a wide range of comprehensive evaluations.

We leverage our extensive internal knowledge base and public databases to accelerate your phenotypic drug discovery program.